NeuPath Health Inc. (NPTH) Q3 Revenue Rises 1% to $22.3M; Adjusted EBITDA Falls to $1.4M

Q3 2026 revenue was $22.3M versus $22.1M a year earlier; Adjusted EBITDA was $1.4M versus $1.5M. Nine-month revenue was $67.1M versus $65.0M, including a $1.9M prior-year one-time payment; excluding it, prior-year revenue was $63.2M.Material DetailsContext by AI AnalystThe results show early operat…